Valuation: Virbac

Market Cap 273.12Cr 312.53Cr 252.02Cr 232.3Cr 437.85Cr 30TCr 447.57Cr 3.01TCr 1.18TCr 15TCr 1.17TCr 1.15TCr 51TCr P/E 2026 *
16.1x
P/E 2027 * 14.5x
Enterprise Value 285.22Cr 326.37Cr 263.19Cr 242.6Cr 457.25Cr 31TCr 467.4Cr 3.15TCr 1.24TCr 15TCr 1.23TCr 1.2TCr 53TCr EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.68x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
1 day-0.15%
1 week+1.72%
Current month-1.95%
1 month-1.06%
3 months-14.99%
6 months-8.68%
Current year-8.81%
1 week 317
Extreme 317
328
1 month 312.5
Extreme 312.5
347
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap.
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%+1.72%-8.04%+29.37% 312.53Cr
-0.46%+1.32%-48.48%-55.25% 3.21TCr
-0.46%+4.07%+74.76%+121.72% 1.29TCr
-3.77%+0.13%-21.29%-2.35% 359.4Cr
-3.66%-4.93%+28.67%+20.37% 186.68Cr
+3.69%+10.84%-9.37%+24.63% 185.32Cr
-3.51%+3.87%+13.26%+132.61% 135.12Cr
-3.47%+1.93%-26.25%-13.84% 106.31Cr
-0.15%+8.87%-15.97%-43.96% 100Cr
-1.79%+0.56%-10.30%-19.96% 95Cr
Average -1.37%+3.04%-2.30%+19.33% 597.99Cr
Weighted average by Cap. -0.75%+2.27%-11.58%+1.10%

Financials

2026 *2027 *
Net sales 154.82Cr 177.16Cr 142.86Cr 131.68Cr 248.19Cr 17TCr 253.7Cr 1.71TCr 671.61Cr 8.36TCr 665.31Cr 650.71Cr 29TCr 164.48Cr 188.21Cr 151.77Cr 139.9Cr 263.68Cr 18TCr 269.53Cr 1.81TCr 713.52Cr 8.88TCr 706.82Cr 691.31Cr 31TCr
Net income 17Cr 19Cr 16Cr 14Cr 27Cr 1.86TCr 28Cr 185.88Cr 73Cr 909.59Cr 72Cr 71Cr 3.13TCr 19Cr 22Cr 17Cr 16Cr 30Cr 2.09TCr 31Cr 209.04Cr 82Cr 1.02TCr 81Cr 80Cr 3.52TCr
Net Debt 12Cr 14Cr 11Cr 10Cr 19Cr 1.33TCr 20Cr 133.45Cr 52Cr 653Cr 52Cr 51Cr 2.25TCr 2.65Cr 3.03Cr 2.44Cr 2.25Cr 4.25Cr 291.94Cr 4.34Cr 29Cr 11Cr 142.98Cr 11Cr 11Cr 492.2Cr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
17/26/17 €326.00 -0.15% 3,635
16/26/16 €326.50 +2.03% 5,873
15/26/15 €320.00 -0.62% 6,790
14/26/14 €322.00 -0.77% 2,467
13/26/13 €324.50 +1.25% 5,192
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
326.00EUR
Average target price
412.00EUR
Spread / Average Target
+26.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock